Answers are grounded in this paper and cite their sources.
Direct endoscopic necrosectomy (DEN) represents the first-line treatment for walled-off necrosis (WON). However, DEN has a non-negligible rate of overall adverse events (AE) and is time-consuming due to the lack of dedicated devices. This pilot study was designed to evaluate the feasibility and safety of a novel dedicated device for DEN named Necrolit.
No takes yet. Share an insight, caveat, or question.
Ligresti et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: